HK1253677A1 - 緩釋薄膜包衣膠囊 - Google Patents

緩釋薄膜包衣膠囊

Info

Publication number
HK1253677A1
HK1253677A1 HK18112818.5A HK18112818A HK1253677A1 HK 1253677 A1 HK1253677 A1 HK 1253677A1 HK 18112818 A HK18112818 A HK 18112818A HK 1253677 A1 HK1253677 A1 HK 1253677A1
Authority
HK
Hong Kong
Prior art keywords
release film
extended release
coated capsules
capsules
coated
Prior art date
Application number
HK18112818.5A
Other languages
English (en)
Inventor
Irena Mcguffy
William M Bell
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of HK1253677A1 publication Critical patent/HK1253677A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891Coated capsules; Multilayered drug free capsule shells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • A61K9/4825Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833Encapsulating processes; Filling of capsules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
HK18112818.5A 2015-10-30 2018-10-09 緩釋薄膜包衣膠囊 HK1253677A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14/928,029 US20170119680A1 (en) 2015-10-30 2015-10-30 Extended release film-coated capsules

Publications (1)

Publication Number Publication Date
HK1253677A1 true HK1253677A1 (zh) 2019-06-28

Family

ID=57233954

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18112818.5A HK1253677A1 (zh) 2015-10-30 2018-10-09 緩釋薄膜包衣膠囊

Country Status (10)

Country Link
US (1) US20170119680A1 (zh)
EP (1) EP3368019A1 (zh)
JP (1) JP2018531985A (zh)
CN (1) CN108601743A (zh)
AU (1) AU2016344402A1 (zh)
BR (1) BR112018008617A2 (zh)
CA (1) CA3003644A1 (zh)
HK (1) HK1253677A1 (zh)
MX (1) MX2018005456A (zh)
WO (1) WO2017075215A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020044121A1 (en) * 2018-08-27 2020-03-05 Emerald Health Therapeutics Canada Inc. Oral formulations of phenylalanine and cannabinoids
CN112955158A (zh) 2018-09-05 2021-06-11 康肾医药有限公司 含铁组合物及其用途
KR20220024189A (ko) * 2019-06-03 2022-03-03 알.피.쉐러 테크놀러지즈 엘엘씨 지연 방출 소프트젤 캡슐
WO2021011538A1 (en) * 2019-07-15 2021-01-21 R.P. Scherer Technologies, Llc Capsule dosage forms, methods of preparation and methods of use thereof
EP4121036A4 (en) * 2020-03-18 2024-04-10 Scherer Technologies Llc R P SOFT GEL CAPSULES
US20230225980A1 (en) * 2020-06-02 2023-07-20 R.P. Scherer Technologies, Llc Delayed release softgel capsules
US20230390210A1 (en) * 2020-10-16 2023-12-07 R.P. Scherer Technologies, Llc Modified release softgel capsules
AR126384A1 (es) * 2021-07-06 2023-10-11 Scherer Technologies Llc R P Cápsula blanda

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK164642C (da) 1984-08-30 1992-12-14 Merrell Dow Pharma Farmaceutisk middel indeholdende terfenadin i form af en varmsmelte paafyldt paa kapsler
US5120548A (en) 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
IT1245891B (it) 1991-04-12 1994-10-25 Alfa Wassermann Spa Formulazioni farmaceutiche a rilascio controllato per uso orale gastroresistenti contenenti acidi biliari e loro sali.
US6204243B1 (en) * 1993-09-01 2001-03-20 Novatis Ag Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis
NL1009107C2 (nl) 1997-11-12 1999-06-15 Banner Pharmacaps Inc Gelatine-uitspreidende doos met meervoudige, aanpasbare poortklep en meerlagig zacht gel.
AU748996B2 (en) 1998-11-11 2002-06-13 Bioprogress Technology International, Inc. A capsule based drug delivery system
DK1140012T3 (da) 1998-12-17 2004-07-12 Alza Corp Omdannelse af væskefyldte gelatinekapsler til systemer til kontrolleret frigivelsessystemer ved flere coatinger
US20020114832A1 (en) 2000-12-11 2002-08-22 Dr. Willmar Schwabe Gmbh & Co. Pharmaceutical preparation comprising peppermint oil and caraway oil in delayed release form
WO2002087543A1 (en) 2001-05-01 2002-11-07 Biozone Laboratories, Inc. Sustained release formulations for nifedipine, dextromethorphan, and danazol
US20030092765A1 (en) 2001-11-15 2003-05-15 John Kelly Treatment of abnormal increases in gastrointestinal motility with (R)-verapamil
SI1578350T1 (sl) 2002-03-26 2009-10-31 Euro Celtique Sa Z gelom obloženi sestavki z zadržanim sproščanjem
FR2838349B1 (fr) 2002-04-15 2004-06-25 Laurence Paris Compositions liquides pour capsules molle a liberation prolongee et leur procede de fabrication
EP1572164A2 (en) 2002-12-18 2005-09-14 Pain Therapeutics, Inc. Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
US20050152967A1 (en) 2003-03-28 2005-07-14 Pfab, Lp Dynamic variable release
CA2522298A1 (en) * 2003-04-14 2004-10-28 Fmc Corporation Homogeneous, thermoreversible alginate films and soft capsules made therefrom
US7737133B2 (en) 2003-09-03 2010-06-15 Agi Therapeutics Ltd. Formulations and methods of treating inflammatory bowel disease
AU2005231145B8 (en) 2004-03-31 2010-11-11 Bpsi Holdings, Inc. Enteric coatings for orally ingestible substrates
CA2581764A1 (en) * 2004-09-27 2006-04-06 Sigmoid Biotechnologies Limited Minicapsule formulations
US20090017110A1 (en) 2005-05-31 2009-01-15 Capricorn Pharma Inc. Modified release formulations of anti-irritability drugs
US20070082046A1 (en) 2005-10-11 2007-04-12 Banner Pharmacaps, Inc. Enteric valproic acid
EP2081550B2 (en) 2006-03-09 2021-05-26 Reliant Pharmaceuticals, Inc. Coating capsules with active pharmaceutical ingredients
JP5457830B2 (ja) 2006-04-03 2014-04-02 オディディ,イサ オルガノゾル被膜を含む制御放出送達デバイス
US20080187579A1 (en) * 2007-02-01 2008-08-07 Pavan Bhat Extended-release dosage form
CN101049380A (zh) * 2007-05-11 2007-10-10 张冰文 含有山茶油的肠溶软胶囊及其制备方法
US20090136650A1 (en) 2007-09-18 2009-05-28 Viva Pharmaceuticals Inc. Enteric coatings for orally ingestible compositions
US8309107B2 (en) 2008-10-06 2012-11-13 Banner Pharmacaps, Inc. Stable solutions of orlistat for pharmaceutical dosage forms
US20100291201A1 (en) 2009-05-14 2010-11-18 Cerovene, Inc. Coated pharmaceutical capsule dosage form
CN103169685B (zh) * 2011-12-23 2018-03-06 石药集团中奇制药技术(石家庄)有限公司 一种丁苯酞控释制剂及其制备方法
US20160193155A1 (en) * 2013-09-02 2016-07-07 Sun Pharmaceutical Industries Limited Pulsatile-release dosage form

Also Published As

Publication number Publication date
EP3368019A1 (en) 2018-09-05
AU2016344402A1 (en) 2018-05-17
JP2018531985A (ja) 2018-11-01
CN108601743A (zh) 2018-09-28
US20170119680A1 (en) 2017-05-04
MX2018005456A (es) 2018-11-09
WO2017075215A1 (en) 2017-05-04
BR112018008617A2 (pt) 2018-10-30
CA3003644A1 (en) 2017-05-04

Similar Documents

Publication Publication Date Title
EP3273948A4 (en) Liquisoft capsules
AU356804S (en) Tablet
HK1253677A1 (zh) 緩釋薄膜包衣膠囊
GB201608157D0 (en) Capsules
SG11201701296VA (en) Processes for preparing multiple capsules
IL266022A (en) Capsule with controlled release
IL254818A0 (en) Ribociclib tablet
HK1215385A1 (zh) 改進釋放的被覆蓋的膠囊
GB2547028B (en) Early connection release
HK1249857A1 (zh) 片劑
GB201420300D0 (en) Tablet
GB201415681D0 (en) Protien Capsules
GB201412955D0 (en) Supramolecular capsules
SI3145499T1 (sl) Obložene kapsule s prirejenim sproščanjem
IL250160A0 (en) medicinal substance
AU356801S (en) Tablet
ZA201800184B (en) Extended release capecitabine capsules
EP3431079C0 (en) COMPRESSED
GB201511252D0 (en) Tablet
HK1252537B (zh) 殺蟎劑
GB201716001D0 (en) EG tipex etc capsules
GB201509538D0 (en) Hellum capsules
GB201511552D0 (en) A release agent
GB201513140D0 (en) Release me
GB201519826D0 (en) Release mechanism